|
Volumn 25, Issue 1, 2002, Pages 57-62
|
Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors
|
Author keywords
Drug resistance; Genotype; Human immunodeficiency virus type 1; Phenotype
|
Indexed keywords
ABACAVIR;
ANTIRETROVIRUS AGENT;
DELAVIRDINE;
DIDANOSINE;
EFAVIRENZ;
INDINAVIR;
LAMIVUDINE;
NELFINAVIR;
NEVIRAPINE;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
ZALCITABINE;
ZIDOVUDINE;
ALGORITHM;
ANTIBIOTIC RESISTANCE;
ARTICLE;
ASSAY;
BLOOD SAMPLING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DATA ANALYSIS;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC ERROR;
DRUG SENSITIVITY;
GENOTYPE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTERMETHOD COMPARISON;
LABORATORY;
MULTIDRUG RESISTANCE;
PHENOTYPE;
PRIORITY JOURNAL;
|
EID: 0036065416
PISSN: 13866532
EISSN: None
Source Type: Journal
DOI: 10.1016/s1386-6532(01)00252-9 Document Type: Article |
Times cited : (18)
|
References (17)
|